Logo image of CMBT.BR

CMB TECH NV (CMBT.BR) Stock Fundamental Analysis

Europe - EBR:CMBT - BE0003816338 - Common Stock

8.62 EUR
+0.41 (+4.99%)
Last: 9/26/2025, 3:37:02 PM
Fundamental Rating

4

Taking everything into account, CMBT scores 4 out of 10 in our fundamental rating. CMBT was compared to 64 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT scores excellent on profitability, but there are concerns on its financial health. While showing a medium growth rate, CMBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CMBT was profitable.
In the past year CMBT had a positive cash flow from operations.
CMBT had positive earnings in 4 of the past 5 years.
CMBT had a positive operating cash flow in 4 of the past 5 years.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

The Return On Assets of CMBT (4.58%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 29.01%, CMBT belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
The Return On Invested Capital of CMBT (3.87%) is worse than 68.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMBT is in line with the industry average of 9.91%.
The last Return On Invested Capital (3.87%) for CMBT is well below the 3 year average (8.95%), which needs to be investigated, but indicates that CMBT had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROIC 3.87%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBT has a Profit Margin of 25.21%. This is amongst the best in the industry. CMBT outperforms 85.94% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
Looking at the Operating Margin, with a value of 25.71%, CMBT is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
In the last couple of years the Operating Margin of CMBT has grown nicely.
With a decent Gross Margin value of 54.54%, CMBT is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
CMBT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CMBT has been reduced compared to 5 years ago.
Compared to 1 year ago, CMBT has a worse debt to assets ratio.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CMBT has an Altman-Z score of 0.73. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
CMBT has a Altman-Z score of 0.73. This is in the lower half of the industry: CMBT underperforms 76.56% of its industry peers.
CMBT has a Debt/Equity ratio of 3.82. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.82, CMBT is doing worse than 93.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Altman-Z 0.73
ROIC/WACC0.53
WACC7.29%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.82 indicates that CMBT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, CMBT is doing worse than 85.94% of the companies in the same industry.
A Quick Ratio of 0.75 indicates that CMBT may have some problems paying its short term obligations.
CMBT has a Quick ratio of 0.75. This is amonst the worse of the industry: CMBT underperforms 84.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.75
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The earnings per share for CMBT have decreased strongly by -99.67% in the last year.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.41% on average per year.
The Revenue has decreased by -1.96% in the past year.
Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%

3.2 Future

Based on estimates for the next years, CMBT will show a very negative growth in Earnings Per Share. The EPS will decrease by -39.46% on average per year.
The Revenue is expected to grow by 31.58% on average over the next years. This is a very strong growth
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue Next Year45.47%
Revenue Next 2Y36.6%
Revenue Next 3Y31.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 431.00 indicates a quite expensive valuation of CMBT.
Based on the Price/Earnings ratio, CMBT is valued a bit more expensive than 71.88% of the companies in the same industry.
CMBT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.06.
With a Price/Forward Earnings ratio of 5.33, the valuation of CMBT can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMBT indicates a rather cheap valuation: CMBT is cheaper than 96.88% of the companies listed in the same industry.
CMBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.64.
Industry RankSector Rank
PE 431
Fwd PE 5.33
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMBT indicates a slightly more expensive valuation: CMBT is more expensive than 70.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.3
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The decent profitability rating of CMBT may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -39.46% in the coming years.
PEG (NY)N/A
PEG (5Y)9.93
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%

0

5. Dividend

5.1 Amount

CMBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

EBR:CMBT (9/26/2025, 3:37:02 PM)

8.62

+0.41 (+4.99%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.72B
Analysts82
Price Target9.9 (14.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.84
Dividend Growth(5Y)116.35%
DP59.41%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.53%
Min EPS beat(2)-198.04%
Max EPS beat(2)-149.02%
EPS beat(4)0
Avg EPS beat(4)-100.08%
Min EPS beat(4)-198.04%
Max EPS beat(4)-3.67%
EPS beat(8)4
Avg EPS beat(8)61.43%
EPS beat(12)7
Avg EPS beat(12)47.26%
EPS beat(16)10
Avg EPS beat(16)41.59%
Revenue beat(2)1
Avg Revenue beat(2)18.49%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)13.62%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)20.12%
Revenue beat(12)10
Avg Revenue beat(12)34.18%
Revenue beat(16)14
Avg Revenue beat(16)38.38%
PT rev (1m)-7.62%
PT rev (3m)-12.59%
EPS NQ rev (1m)-96.97%
EPS NQ rev (3m)-97.22%
EPS NY rev (1m)0%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)22.04%
Revenue NQ rev (3m)45.64%
Revenue NY rev (1m)7.62%
Revenue NY rev (3m)35.76%
Valuation
Industry RankSector Rank
PE 431
Fwd PE 5.33
P/S 2.09
P/FCF N/A
P/OCF 11.86
P/B 2.41
P/tB 2.81
EV/EBITDA 13.3
EPS(TTM)0.02
EY0.23%
EPS(NY)1.62
Fwd EY18.77%
FCF(TTM)-2.57
FCFYN/A
OCF(TTM)0.73
OCFY8.43%
SpS4.12
BVpS3.58
TBVpS3.07
PEG (NY)N/A
PEG (5Y)9.93
Profitability
Industry RankSector Rank
ROA 4.58%
ROE 29.01%
ROCE 5.15%
ROIC 3.87%
ROICexc 3.95%
ROICexgc 4.05%
OM 25.71%
PM (TTM) 25.21%
GM 54.54%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
ROICexc(3y)9.88%
ROICexc(5y)N/A
ROICexgc(3y)9.93%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 3.82
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 492%
Cap/Sales 80.04%
Interest Coverage 1.85
Cash Conversion 42.05%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.75
Altman-Z 0.73
F-Score2
WACC7.29%
ROIC/WACC0.53
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.96%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%
Revenue Next Year45.47%
Revenue Next 2Y36.6%
Revenue Next 3Y31.58%
Revenue Next 5YN/A
EBIT growth 1Y-41.59%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-427.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.74%
OCF growth 3YN/A
OCF growth 5Y11.04%